The Impact of Chronic Kidney Disease and Short-Term Treatment with Rosiglitazone on Plasma Cell-Free DNA Levels

by Amanda L. McGuire, Nadia Urosevic, Doris T. Chan, Gursharan Dogra, Timothy J. J. Inglis, Aron Chakera
Published 2014-01-01

Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-III

by Doris T. Chan, Gursharan K. Dogra, Ashley B. Irish, Esther M. Ooi, P. Hugh Barrett, Dick C. Chan, Gerald F. Watts
Published 2009-12-01

Variables associated with successful vascular access cannulation in hemodialysis patients: a prospective cohort study

by Linda L. Coventry, Jon M. Hosking, Doris T. Chan, Evelyn Coral, Wai H. Lim, Amanda Towell-Barnard, Diane E. Twigg, Claire M. Rickard
Published 2019-05-01

Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease

by Esther M.M. Ooi, Doris T. Chan, Gerald F. Watts, Dick C. Chan, Theodore W.K. Ng, Gursharan K. Dogra, Ashley B. Irish, P. Hugh R. Barrett
Published 2011-04-01